AC Immune SA (ACIU)
NASDAQ: ACIU · IEX Real-Time Price · USD
2.960
-0.070 (-2.31%)
At close: Mar 28, 2024, 4:00 PM
2.940
-0.020 (-0.68%)
After-hours: Mar 28, 2024, 7:39 PM EDT

AC Immune Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Revenue
14.83.94015.43110.466.9120.2623.2139.0930.27
Revenue Growth (YoY)
276.14%---86.03%1498.03%-65.88%-12.75%-40.61%29.14%-
Gross Profit
14.83.94015.43110.466.9120.2623.2139.0930.27
Selling, General & Admin
15.3115.7917.9118.5616.0612.4710.137.93.423.44
Research & Development
54.6160.3462.2859.4950.4344.2832.6625.7717.0516.12
Other Operating Expenses
-1.49-1.34-1.18-1.35-0.57-0.280000
Operating Expenses
68.4374.7879.0176.6965.9256.4642.7933.6720.4719.55
Operating Income
-53.62-70.85-79.01-61.2644.54-49.55-22.54-10.4618.6210.72
Interest Expense / Income
0.180.360.580.181.930.330.150.0100
Other Expense / Income
0.42-0.46-6.60.48-2.831.073.73-3.37-1.65-0.03
Pretax Income
-54.22-70.74-72.99-61.9245.44-50.95-26.41-7.120.2710.74
Income Tax
0.010.0100000000
Net Income
-54.23-70.75-73-61.9245.44-50.95-26.41-7.120.2710.74
Net Income Growth
--------88.66%-
Shares Outstanding (Basic)
85847372685757504343
Shares Outstanding (Diluted)
------57504646
Shares Change
0.30%15.88%1.43%6.36%17.80%0.47%13.95%8.80%1.08%-
EPS (Basic)
-0.64-0.85-0.97-0.860.64-0.82-0.46-0.140.470.25
EPS (Diluted)
-0.64-0.85-0.97-0.860.64-0.82-0.46-0.140.440.24
EPS Growth
--------83.33%-
Free Cash Flow
-61.63-74.4-67.85-60.8953.34-45.63-24.07-6.4643.79-17.77
Free Cash Flow Per Share
-0.73-0.88-0.93-0.850.79-0.80-0.42-0.131.01-0.42
Gross Margin
100.00%100.00%-100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-362.30%-1800.43%--396.99%40.32%-716.87%-111.28%-45.04%47.64%35.41%
Profit Margin
-366.41%-1798.04%--401.28%41.14%-737.14%-130.39%-30.57%51.85%35.50%
Free Cash Flow Margin
-416.38%-1890.67%--394.59%48.29%-660.16%-118.85%-27.84%112.03%-58.70%
EBITDA
-51.83-68.03-70.01-59.7749.06-49.66-25.68-6.8120.5611.05
EBITDA Margin
-350.19%-1728.74%--387.34%44.42%-718.40%-126.80%-29.34%52.59%36.49%
Depreciation & Amortization
2.222.362.411.971.690.960.580.280.290.3
EBIT
-54.05-70.39-72.41-61.7447.37-50.62-26.26-7.0920.2710.75
EBIT Margin
-365.16%-1788.69%--400.08%42.88%-732.31%-129.67%-30.54%51.85%35.51%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).